Development of cyclic peptides that can be administered orally to inhibit disease targets

Nat Chem Biol. 2024 May;20(5):551-552. doi: 10.1038/s41589-023-01505-0.
No abstract available

MeSH terms

  • Administration, Oral
  • Animals
  • Drug Development / methods
  • Humans
  • Peptides, Cyclic* / administration & dosage
  • Peptides, Cyclic* / chemistry
  • Peptides, Cyclic* / pharmacology

Substances

  • Peptides, Cyclic